Pennsylvania’s Patient Safety Authority Selects MedStar Health Research Institute to Improve Patient Safety through Innovative Machine Learning

MedStar Health Research Institute has been awarded a contract from Pennsylvania's Patient Safety Authority for a multi-year project analyzing the largest patient safety database in the country. Led by principal investigator Raj Ratwani, PhD, the collaborative team from the MedStar Health National Center for Human Factors in Healthcare will use innovative machine learning algorithms to quickly identify areas where improvements can be applied to shape the future of safe and effective patient care. Pennsylvania is the only state in the U.S. that requires healthcare facilities to report events that could potentially cause harm to patients, as well as events that have been shown to cause harm. Read more.

Contact

Eva Hochberger
Communications & Planning Manager, MHRI
[email protected]

MedStar Research on EHR Safety Cited in Fortune Magazine

Raj Ratwani, PhD, Center Director & Scientific Director of the National Center for Human Factors in Healthcare has made tremendous development in researching EHR safety and usability. The illustrious Fortune Magazine highlighted these efforts in an article titled “Death by a Thousand Clicks: Where Electronic Health Records Went Wrong”. Congratulations to Dr. Ratwani and his team for being recognized! Read more.

Contact

Eva Hochberger
Communications & Planning Manager, MHRI
[email protected]

MedStar Investigator Presents at the American College of Cardiology Scientific Session

Frederico M. Asch, MD presented analysis from his late breaking clinical trial, COAPT. The echocardiography characteristics of the COAPT population, strengthens the need to identify a consistent baseline for enrolling patients in an effort to replicate similar results when used in clinical practice. “…clearly the fact that the results were so different, the outcomes were so different, makes it extremely important that we understand who exactly was enrolled in COAPT,” Asch said. Learn more

Contact

Eva Hochberger
Communications & Planning Manager, MHRI
[email protected]

ObEN Creates Healthcare Avatar for MedStar Health Heart Disease Study

 

Personal AI of nurse to aid in at-home monitoring of patients suffering from heart failure

Pasadena, CA/Hyattsville, MD (March 4, 2019) — ObEN Inc., the artificial intelligence (AI) company creating Personal AI (PAI) technology to revolutionize digital interactions, is pleased to announce it is working with MedStar Health Research Institute for a study on the use of Personal AI (PAI) healthcare assistants for patients suffering from heart failure. For the study, ObEN has created a medical health assistant app, called PAI Care, to help monitor patients of heart failure.

Under the direction of the principal investigator Nawar Shara, PhD, Director of the Department of Biostatistics and Biomedical Informatics at MedStar Health Research Institute and Associate Professor of Medicine at Georgetown University, the study will investigate the use of voice-activated and avatar-enabled technologies for monitoring heart failure patients at home and whether this monitoring improves health and recovery outcomes. The study will include patients interacting with Tara, an intelligent 3D Healthcare Assistant Avatar created using ObEN’s PAI technology, via an app on a tablet.

“Heart failure is a chronic, progressive condition that impacts millions of people worldwide and is increasing in incidence,”said Dr. Shara. “Hospitalization is a major driver of treatment costs and adversely affects the quality of life and outcomes for heart failure patients. Prevention of heart failure hospital readmission is an area of unmet need. This study leverages voice and avatar-enabled artificial intelligence technologies to empower patients to better manage their condition.”

For this four-month study, ObEN’s technology will fuel the voice, appearance, and animation of the healthcare assistant avatar in PAI Care as well as the chatbot feature through which the patients can interact with the PAI. Under a daily schedule, participants in the study will answer a series of health and wellness questions that will help the study collect data and also monitor the health of the patients.

ObEN is also providing additional technology for a related-study by MedStar Health Research Institute, using voice-enabled healthcare support. This study is made possible with grant funding from the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) through the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS).

“ObEN’s technology can potentially create a way to provide triage, management, and routine health reminders while alleviating pain points within the healthcare industry including patient monitoring, EHS systems management, and geriatric care and companionship,” said Nikhil Jain, CEO of ObEN. “With the healthcare industry facing rising costs, insufficient resources and a lack of manpower around the world, we believe PAI can serve as the basis for solutions to the most pressing issues in healthcare and provide better access to service for all people.”

Using ObEN’s proprietary full-stack AI technology, ObEN can create personalized, intelligent 3D avatars that look and sound like the user, can learn to behave like the user, and even learn skills the user does not possess, like speaking in multiple languages. ObEN has also adopted the Project PAI blockchain protocol, an open source decentralized public utility blockchain, to secure and authenticate the PAIs and the associated user data, allowing people to gain more ownership of their own digital identity. For healthcare applications, ObEN enables the creation of Nurse and Doctor PAIs that can be individualized to the real professionals providing care to their patients.

To learn more about Personal AI technology visit oben.com


About ObEN
ObEN is an artificial intelligence (AI) company developing Personal AI technology that revolutionizes personal digital interaction, enabling never before possible social and virtual interactions. The company’s technology allows users to create intelligent 3D avatars that look, sound, and behave like them. Deployed on the Project PAI blockchain, ObEN’s Personal AI (PAI) technology enables users to create, use, and manage their own PAI on a secure, decentralized platform. Founded in 2014, ObEN is a K11, Tencent, Softbank Ventures Korea and HTC Vive X portfolio company and is located at Idealab in Pasadena, California. To learn more about ObEN, please visit oben.com.

About MedStar Health Research Institute
MedStar Health Research Institute is the research arm of MedStar Health, the largest healthcare provider in Maryland and the Washington, D.C., region. MHRI provides scientific, administrative, and regulatory support for research programs throughout the MedStar Health system. MHRI’s expertise includes translational research into disease prevention, diagnosis, and treatment. These programs complement the key clinical services and teaching programs in the 10 MedStar hospitals and other MedStar entities. For more information, visit MedStarResearch.org.

About MedStar Health
MedStar Health is a not-for-profit health system dedicated to caring for people in Maryland and the Washington, D.C., region while advancing the practice of medicine through education, innovation, and research. MedStar’s 30,000 associates, 6,000 affiliated physicians, 10 hospitals, ambulatory care and urgent care centers, and the MedStar Health Research Institute are recognized regionally and nationally for excellence in medical care. As the medical education and clinical partner of Georgetown University, MedStar trains more than 1,100 medical residents annually. MedStar Health’s patient-first philosophy combines care, compassion, and clinical excellence with an emphasis on customer service. For more information, visit MedStarHealth.org.

Newsroom

Click below to go to our Newsroom.

Contact

Eva Hochberger
Communications & Planning Manager, MHRI
[email protected]

Lisa Wang
Senior Marketing Manager, ObEN
[email protected]

MedStar Research Supports Collaborative Call for EHR Improvements

In a joint effort, experts from MedStar Health and the American Medical Association (AMA) have launched EHRSeeWhatWeMean.org, highlighting patient safety and health information technology concerns with electronic health records (EHRs). 2019 marks the 10-year anniversary of the federal act which encouraged the adoption of EHRs. This collaboration builds on prior MedStar Health research that identified concerns with EHRs usability and errors. Read more.

Recent Posts

Contact

Eva Hochberger
Communications & Planning Manager, MHRI
[email protected]

Lisa Wang
Senior Marketing Manager, ObEN
[email protected]

MedStar Health Research Institute Awarded Research Grants from the Charles and Mary Latham Fund

 

Hyattsville, MD (January 31, 2019) — Three research projects at MedStar Health Research Institute were awarded grant funding through the Charles and Mary Latham Fund. The Fund was established by Ella O. Latham, to support medical research in the Washington, D.C., metropolitan area.

Three MedStar Health physician-investigators were awarded funding for their research projects:

  • Jessica Galarraga, MD, MPH: An Evaluation of Hospital Readmissions in the District of Columbia
  • Suhasini Kaushal, MD: Identifying Early Neuroimaging Biomarkers using Diffusivity Measures and Functional Connectivity to Predict Neurodevelopmental Outcomes in Neonates with Hypoxic-Ischemic Injury
  • Angela D. Thomas, DrPH, MPH, MBA: Measuring, Assessing, and Understanding Race Differences in Adverse Patient Safety Events in an Urban, Teaching Hospital in Washington, DC using the IHI Global Trigger Tool

“These research projects exemplify MedStar’s commitment to advancing health through research throughout the Washington, D.C. metro community,” said Neil J. Weissman, MD, president of MedStar Health Research Institute and chief scientific officer for MedStar Health. “As an academic health system, we are extremely appreciative for the support we have received from the Charles and Mary Latham Fund to improve health outcomes for everyone in our community.”

The Charles and Mary Latham Fund was established by Ella O. Latham in memory of her parents. Founded in 1972, the Fund has supported a myriad of worthwhile projects relating to medical research for the cure of diseases in the human body with a preference for clinical applications and medical, nursing, and hospital care for persons suffering from such diseases who are financially unable to provide their own care. SunTrust Bank is the Fund’s trustee. The relationship is managed by the SunTrust Foundations and Endowments Specialty Practice.

 

###

About MedStar Health Research Institute
The MedStar Health Research Institute is the research arm of MedStar Health, the largest healthcare provider in Maryland and the Washington, D.C., region. MHRI provides scientific, administrative and regulatory support for research programs throughout the MedStar Health system. MHRI’s expertise includes translational research into disease prevention, diagnosis, and treatment. These programs complement the key clinical services and teaching programs in the 10 MedStar hospitals and other MedStar entities. Visit us at www.MedStarResearch.org

About MedStar Health
MedStar Health is a not-for-profit health system dedicated to caring for people in Maryland and the Washington, D.C., region, while advancing the practice of medicine through education, innovation, and research. MedStar’s 31,000 associates, 6,500 affiliated physicians, 10 hospitals, ambulatory care, and urgent care centers, and the MedStar Health Research Institute are recognized regionally and nationally for excellence in medical care. As the medical education and clinical partner of Georgetown University, MedStar trains more than 1,100 medical residents annually. MedStar Health’s patient-first philosophy combines care, compassion and clinical excellence with an emphasis on customer service. For more information, visit www.MedStarHealth.org.

Newsroom

Click below to go to our Newsroom.

Contact

Eva Hochberger
Communications & Planning Manager
Phone: 301-560-2917
[email protected] 

Program Director of the MedStar Diabetes Institute joins ADA National Board of Directors

 

Gretchen Youssef, MS, RD, CDE, President, Health Care & Education became a member of the American Diabetes Association Principal Officers and National Board of Directors for 2019. The American Diabetes Association (ADA) is the nation's leading voluntary health organization on a mission to prevent and cure diabetes, as well as improve the lives of all people affected by the disease. Read more. 

Newsroom

Click below to go to our Newsroom.

Contact

Eva Hochberger
Communications & Planning Manager, MHRI
[email protected]

Lisa Wang
Senior Marketing Manager, ObEN
[email protected]

MedStar Health Awarded Grant to Improve Hepatitis C Diagnosis Clinical Knowledge at Point of Care


Columbia, MD (December 17, 2018) 
—The Coverys Community Healthcare Foundation, Inc. (Foundation) put out a call to action and distributed a request for proposals for projects focused on improving diagnostic accuracy. The Foundation put aside $3 million in funding for approved projects. The Foundation received an overwhelming response to the request for proposals and MedStar Health’s proposal, titled “Improving diagnostic accuracy for Hepatitis C with a validated teach/improve model” was one of the 11 grant recipients selected for funding. Read more

Recent Posts

Contact

Eva Hochberger
Communications & Planning Manager
Phone: 301-560-2917
[email protected] 

Innovative Stem Cell Therapeutic Strategy May be Transformative for Heart Failure Treatment


Washington, D.C., (December 4, 2018)
—MedStar Heart in partnership with CardioCell has been approved to conduct an investigational new drug clinical trial, called STEMVAD at MedStar Heart & Vascular Institute. The goal of this study is to determine whether stem cell therapy improves myocardial function in patients with severe heart failure. “Innovative therapies to improve heart function and outcomes of patients with advanced heart failure are sorely needed,” said Selma Mohammed, MD, PhD.  Read more.

Recent Posts

Contact

Eva Hochberger
Communications & Planning Manager
Phone: 301-560-2917
[email protected]